These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7132492)

  • 1. [Cytochemical assessment of malignancy of breast tumor].
    Auer G; Caspersson T
    Lakartidningen; 1982 May; 79(20):2018-20. PubMed ID: 7132492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological characteristics of breast cancers with various DNA content].
    Loboda VI
    Vopr Onkol; 1980; 26(12):23-8. PubMed ID: 7467215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Feulgen hydrolysis profile and breast carcinoma: a preliminary study.
    Mays RG; Elston CW; Ellis IO; Blamey RW; Dowe CS
    Med Lab Sci; 1988 Jan; 45(1):40-4. PubMed ID: 3200127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proceedings: DNA pattern in breast carcinomas, precancerous and nonproliferating mastopathies].
    Sachs H; Glasenapp U; Winzer K; Stegner HE
    Verh Dtsch Ges Pathol; 1975; 59():500. PubMed ID: 1217106
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytospectrophotometry in the grading of malignant breast tumors].
    Lazzari G; Vineis C
    Ann Osp Maria Vittoria Torino; 1980; 23(1-6):112-25. PubMed ID: 7294645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative DNA analysis of breast cancer by flow cytometry and image analysis.
    Borgiani L; Cogorno P; Toso F; Gallo L; Buccaran G; Rovida S; Canepa M
    Pathologica; 1994 Aug; 86(4):356-9. PubMed ID: 7535909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term survival in terms of DNA-RNA contents in breast cancer].
    Hara S; Kondo M; Tagawa Y; Itoyanagi N; Kishimoto K; Matuo S; Akamine S; Takahashi T; Oka T; Ayabe H
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():422-5. PubMed ID: 9589046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary carcinoma of the breast.
    Pedersen L
    APMIS Suppl; 1997; 75():1-31. PubMed ID: 9439575
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic factors in breast cancer].
    Jonat W; Eidtmann H; Friedrichs K
    Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy and TLI in association with other prognostic parameters in breast cancer.
    Midulla C; Cenci M; De Iorio P; Pisani T; Bonaccorsi A; De Marchis L; Nofroni I; Vecchione A
    Anticancer Res; 1999; 19(1A):381-4. PubMed ID: 10226571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of DNA content and proliferative rate of the invasive carcinoma found in the mammographically directed breast biopsy.
    Bennington JL
    Pathology (Phila); 1992; 1(1):137-60. PubMed ID: 9420918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA analysis in advanced breast cancer.
    Leivonen M; Krogerus L; Nordling S
    Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
    Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
    Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA index as prognostic factor in breast cancer.
    Rzymowska J; Skierski J; Kurylcio L; Dyrda Z
    Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Antonucci JV; Goldstein N; Wallace M; Kestin L; Krauss D; Kunzmann J; Gilbert S; Schell S
    Cancer; 2007 Apr; 109(7):1264-72. PubMed ID: 17372920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
    Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
    Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between DNA ploidy and survival in breast cancer].
    Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():431-5. PubMed ID: 9589048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.